BERKSHIRE HATHAWAY INC-CL B (BRYN.DE) Stock Fundamental Analysis
Europe - FRA:BRYN - US0846707026 - Common Stock
424.3 EUR
-1.3 (-0.31%)
BRYN gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 50 industry peers in the Financial Services industry. BRYN has only an average score on both its financial health and profitability. BRYN scores decently on growth, while it is valued quite cheap. This could make an interesting combination. With these ratings, BRYN could be worth investigating further for value investing!.
1. Profitability
1.1 Basic Checks
In the past year BRYN was profitable.
In the past year BRYN had a positive cash flow from operations.
Of the past 5 years BRYN 4 years were profitable.
In the past 5 years BRYN always reported a positive cash flow from operatings.
1.2 Ratios
The Return On Assets of BRYN (5.41%) is better than 80.00% of its industry peers.
BRYN has a Return On Equity of 9.42%. This is in the better half of the industry: BRYN outperforms 66.00% of its industry peers.
BRYN's Return On Invested Capital of 4.37% is in line compared to the rest of the industry. BRYN outperforms 60.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for BRYN is below the industry average of 8.73%.
The last Return On Invested Capital (4.37%) for BRYN is above the 3 year average (4.13%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.41% | ||
| ROE | 9.42% | ||
| ROIC | 4.37% |
ROA(3y)4.77%
ROA(5y)5.71%
ROE(3y)8.68%
ROE(5y)10.68%
ROIC(3y)4.13%
ROIC(5y)3.72%
1.3 Margins
The Profit Margin of BRYN (17.00%) is better than 74.00% of its industry peers.
In the last couple of years the Profit Margin of BRYN has declined.
Looking at the Operating Margin, with a value of 15.70%, BRYN is in the better half of the industry, outperforming 66.00% of the companies in the same industry.
In the last couple of years the Operating Margin of BRYN has grown nicely.
Looking at the Gross Margin, with a value of 16.97%, BRYN is doing worse than 60.00% of the companies in the same industry.
In the last couple of years the Gross Margin of BRYN has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 15.7% | ||
| PM (TTM) | 17% | ||
| GM | 16.97% |
OM growth 3Y7.37%
OM growth 5Y4.91%
PM growth 3Y-9.72%
PM growth 5Y-5.61%
GM growth 3Y3.45%
GM growth 5Y2.09%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), BRYN is creating some value.
The number of shares outstanding for BRYN has been reduced compared to 1 year ago.
BRYN has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, BRYN has an improved debt to assets ratio.
2.2 Solvency
BRYN has an Altman-Z score of 1.43. This is a bad value and indicates that BRYN is not financially healthy and even has some risk of bankruptcy.
BRYN's Altman-Z score of 1.43 is in line compared to the rest of the industry. BRYN outperforms 46.00% of its industry peers.
The Debt to FCF ratio of BRYN is 15.44, which is on the high side as it means it would take BRYN, 15.44 years of fcf income to pay off all of its debts.
BRYN has a worse Debt to FCF ratio (15.44) than 62.00% of its industry peers.
BRYN has a Debt/Equity ratio of 0.19. This is a healthy value indicating a solid balance between debt and equity.
BRYN's Debt to Equity ratio of 0.19 is fine compared to the rest of the industry. BRYN outperforms 64.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.19 | ||
| Debt/FCF | 15.44 | ||
| Altman-Z | 1.43 |
ROIC/WACC1.36
WACC3.22%
2.3 Liquidity
BRYN has a Current Ratio of 1.95. This is a normal value and indicates that BRYN is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.95, BRYN is in the better half of the industry, outperforming 66.00% of the companies in the same industry.
BRYN has a Quick Ratio of 1.68. This is a normal value and indicates that BRYN is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of BRYN (1.68) is better than 68.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.95 | ||
| Quick Ratio | 1.68 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 8.24% over the past year.
BRYN shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 17.78% yearly.
BRYN shows a small growth in Revenue. In the last year, the Revenue has grown by 0.01%.
The Revenue has been growing slightly by 7.84% on average over the past years.
EPS 1Y (TTM)8.24%
EPS 3Y21.97%
EPS 5Y17.78%
EPS Q2Q%-3.87%
Revenue 1Y (TTM)0.01%
Revenue growth 3Y10.38%
Revenue growth 5Y7.84%
Sales Q2Q%-1.22%
3.2 Future
BRYN is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 2.26% yearly.
Based on estimates for the next years, BRYN will show a small growth in Revenue. The Revenue will grow by 4.89% on average per year.
EPS Next Y-3.47%
EPS Next 2Y0.07%
EPS Next 3Y2.03%
EPS Next 5Y2.26%
Revenue Next Year0.77%
Revenue Next 2Y0.48%
Revenue Next 3Y1.6%
Revenue Next 5Y4.89%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 0.02, the valuation of BRYN can be described as very cheap.
100.00% of the companies in the same industry are more expensive than BRYN, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 27.77, BRYN is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 0.01, the valuation of BRYN can be described as very cheap.
Based on the Price/Forward Earnings ratio, BRYN is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
BRYN's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 23.23.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 0.02 | ||
| Fwd PE | 0.01 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, BRYN is valued cheaper than 94.00% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, BRYN is valued cheaper than 100.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 0.09 | ||
| EV/EBITDA | 0.34 |
4.3 Compensation for Growth
The decent profitability rating of BRYN may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0
EPS Next 2Y0.07%
EPS Next 3Y2.03%
5. Dividend
5.1 Amount
No dividends for BRYN!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
FRA:BRYN (10/22/2025, 1:53:49 PM)
424.3
-1.3 (-0.31%)
Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)
Earnings (Next)
Inst Owners34.67%
Inst Owner ChangeN/A
Ins Owners38.36%
Ins Owner ChangeN/A
Market Cap610.99M
Revenue(TTM)370.15B
Net Income(TTM)62.92B
Analysts80
Price Target454.8 (7.19%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-4.8%
Min EPS beat(2)-9.78%
Max EPS beat(2)0.19%
EPS beat(4)2
Avg EPS beat(4)5.7%
Min EPS beat(4)-10.41%
Max EPS beat(4)42.8%
EPS beat(8)6
Avg EPS beat(8)8.53%
EPS beat(12)8
Avg EPS beat(12)6.49%
EPS beat(16)11
Avg EPS beat(16)7.41%
Revenue beat(2)0
Avg Revenue beat(2)-3.21%
Min Revenue beat(2)-4.09%
Max Revenue beat(2)-2.33%
Revenue beat(4)0
Avg Revenue beat(4)-3.53%
Min Revenue beat(4)-7.69%
Max Revenue beat(4)-0.01%
Revenue beat(8)3
Avg Revenue beat(8)-1.26%
Revenue beat(12)4
Avg Revenue beat(12)-0.85%
Revenue beat(16)5
Avg Revenue beat(16)-1.25%
PT rev (1m)0.23%
PT rev (3m)-1.25%
EPS NQ rev (1m)-0.68%
EPS NQ rev (3m)0.37%
EPS NY rev (1m)0%
EPS NY rev (3m)2.72%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.19%
Revenue NY rev (1m)0%
Revenue NY rev (3m)3.27%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 0.02 | ||
| Fwd PE | 0.01 | ||
| P/S | 0 | ||
| P/FCF | 0.09 | ||
| P/OCF | 0.03 | ||
| P/B | 0 | ||
| P/tB | 0 | ||
| EV/EBITDA | 0.34 |
EPS(TTM)27214.67
EY6414.02%
EPS(NY)28464.17
Fwd EY6708.5%
FCF(TTM)4921
FCFY1159.79%
OCF(TTM)16400.5
OCFY3865.31%
SpS221460.59
BVpS399656.46
TBVpS328207
PEG (NY)N/A
PEG (5Y)0
Graham Number494694
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.41% | ||
| ROE | 9.42% | ||
| ROCE | 5.42% | ||
| ROIC | 4.37% | ||
| ROICexc | 4.82% | ||
| ROICexgc | 5.84% | ||
| OM | 15.7% | ||
| PM (TTM) | 17% | ||
| GM | 16.97% | ||
| FCFM | 2.22% |
ROA(3y)4.77%
ROA(5y)5.71%
ROE(3y)8.68%
ROE(5y)10.68%
ROIC(3y)4.13%
ROIC(5y)3.72%
ROICexc(3y)4.31%
ROICexc(5y)3.94%
ROICexgc(3y)5.19%
ROICexgc(5y)4.78%
ROCE(3y)5.11%
ROCE(5y)4.61%
ROICexgc growth 3Y9.15%
ROICexgc growth 5Y4.04%
ROICexc growth 3Y9.9%
ROICexc growth 5Y4.98%
OM growth 3Y7.37%
OM growth 5Y4.91%
PM growth 3Y-9.72%
PM growth 5Y-5.61%
GM growth 3Y3.45%
GM growth 5Y2.09%
F-Score4
Asset Turnover0.32
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.19 | ||
| Debt/FCF | 15.44 | ||
| Debt/EBITDA | 1.78 | ||
| Cap/Depr | 146.66% | ||
| Cap/Sales | 5.18% | ||
| Interest Coverage | 11.47 | ||
| Cash Conversion | 38.5% | ||
| Profit Quality | 13.07% | ||
| Current Ratio | 1.95 | ||
| Quick Ratio | 1.68 | ||
| Altman-Z | 1.43 |
F-Score4
WACC3.22%
ROIC/WACC1.36
Cap/Depr(3y)148.32%
Cap/Depr(5y)138.32%
Cap/Sales(3y)5.18%
Cap/Sales(5y)5.13%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)8.24%
EPS 3Y21.97%
EPS 5Y17.78%
EPS Q2Q%-3.87%
EPS Next Y-3.47%
EPS Next 2Y0.07%
EPS Next 3Y2.03%
EPS Next 5Y2.26%
Revenue 1Y (TTM)0.01%
Revenue growth 3Y10.38%
Revenue growth 5Y7.84%
Sales Q2Q%-1.22%
Revenue Next Year0.77%
Revenue Next 2Y0.48%
Revenue Next 3Y1.6%
Revenue Next 5Y4.89%
EBIT growth 1Y6.42%
EBIT growth 3Y18.52%
EBIT growth 5Y13.14%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-68.47%
FCF growth 3Y-23.7%
FCF growth 5Y-12.55%
OCF growth 1Y-36.42%
OCF growth 3Y-8.11%
OCF growth 5Y-4.59%